P01.129 Cost-effectiveness of [18F] FET for therapy assessment of temozolomide for patients with glioblastoma in a Belgian healthcare setting
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2018 |
| Reihe/Periodikum: | Neuro-Oncology ; volume 20, issue suppl_3, page iii261-iii262 ; ISSN 1522-8517 1523-5866 |
| Verlag/Hrsg.: |
Oxford University Press (OUP)
|
| Schlagwörter: | Cancer Research / Neurology (clinical) / Oncology |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-28892101 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1093/neuonc/noy139.171 |
